Literature DB >> 7929747

Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

M A Pfaller1, Q Vu, M Lancaster, A Espinel-Ingroff, A Fothergill, C Grant, M R McGinnis, L Pasarell, M G Rinaldi, L Steele-Moore.   

Abstract

MICs of fluconazole and amphotericin B were determined independently for 100 coded yeast isolates by each of six laboratories to determine reproducibility of results by using a colorimetric oxidation-reduction-based broth microdilution test. In addition, each site tested five quality control isolates on at least four different occasions during the study. Results agreed within a three-dilution range (mode +/- 1 log2 dilution) for 96.2% of fluconazole tests and 92.7% of amphotericin B tests. Agreement among tests with the quality control isolates was 99.4% with fluconazole and 98.6% with amphotericin B. These results indicate that the colorimetric microdilution method is reproducible among laboratories.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7929747      PMCID： PMC263742          DOI： 10.1128/jcm.32.7.1625-1628.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  25 in total

1.  Candida species: emerging hospital bloodstream pathogens.

Authors:  R P Wenzel; M A Pfaller
Journal:  Infect Control Hosp Epidemiol       Date:  1991-09       Impact factor: 3.254

2.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

3.  Hospital-acquired candidemia. The attributable mortality and excess length of stay.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1988-12

Review 4.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

5.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

6.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

Review 7.  Impact of the changing epidemiology of fungal infections in the 1990s.

Authors:  M Pfaller; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

Review 8.  Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility.

Authors:  J J Weems
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

9.  Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; T M Kerkering; P R Goldson; S Shadomy
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

Review 10.  Azole antifungal agents.

Authors:  G P Bodey
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079
View more
  23 in total

1.  Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.

Authors:  J Luna-Herrera; G Martínez-Cabrera; R Parra-Maldonado; J A Enciso-Moreno; J Torres-López; F Quesada-Pascual; R Delgadillo-Polanco; S G Franzblau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

2.  Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.

Authors:  I Pujol; J Capilla; B Fernández-Torres; M Ortoneda; J Guarro
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.

Authors:  M A Ghannoum; V Chaturvedi; A Espinel-Ingroff; M A Pfaller; M G Rinaldi; W Lee-Yang; D W Warnock
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.

Authors:  M A Pfaller; A Espinel-Ingroff; R N Jones
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci.

Authors:  C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds.

Authors:  T Yoshida; K Jono; K Okonogi
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Karlsson; A Bolmström
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.

Authors:  M A Pfaller; S Arikan; M Lozano-Chiu; Y Chen; S Coffman; S A Messer; R Rennie; C Sand; T Heffner; J H Rex; J Wang; N Yamane
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Bianca A Bouman; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.